Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts

Zeidan, A. M., Platzbecker, U., Garcia-Manero, G., Sekeres, M. A., Fenaux, P., DeZern, A. E., Greenberg, P. L., Savona, M. R., Jurcic, J. G., Verma, A. K., Mufti, G. J., Buckstein, R., Santini, V., Shetty, J. K., Ito, R., Zhang, J., Zhang, G., Ha, X., Backstrom, J. T., & Komrokji, R. S. (2022). Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts. Blood, 140(20), 2170–2174. https://doi.org/10.1182/blood.2022016171
Authors:
Amer M. Zeidan
Uwe Platzbecker
Guillermo Garcia‐Manero
Mikkael A. Sekeres
Pierre Fenaux
Amy E. DeZern
Peter L. Greenberg
Michael R. Savona
Joseph G. Jurcic
Amit Verma
Ghulam J. Mufti
Rena Buckstein
Valeria Santini
Jeevan K. Shetty
Rodrigo Ito
Jennie Zhang
George Zhang
Xianwei Ha
Jay T. Backstrom
Rami S. Komrokji
Affiliated Authors:
Joseph G. Jurcic
Publication Type:
Article
Unique ID:
10.1182/blood.2022016171
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: